Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma.

Qiwen LiLi MaBo QiuYuzhi WenWenhua LiangWan-Ming HuNaibin ChenTian ZhangShuangbing XuLingjuan ChenMinzhang GuoYi ZhaoSongran LiuJinyu GuoJunye WangSiyu WangXin WangQingsong PangHao LongHui Liu

Published in: Current oncology (Toronto, Ont.) (2021)

Adjuvant TKIs might be a beneficial choice compared with adjuvant chemotherapy or combination systemic treatments.

Keyphrases

early stage
small cell lung cancer
locally advanced
squamous cell carcinoma
decision making
rectal cancer
wild type
drug induced